The Evolving Role of Radiation Oncology in the Management of Uterine Cervical Carcinoma: A State-of-the-Art Review for Non-Radiation Oncologists.

Life (Basel) · 2025 · PMC12734346 · PMID 41465822

Europe PMC DOI

hedged sentence

0.8100

closest p · 16.2× alpha

0.8100

boldest claim

The sentences

did not reach statistical significancep = 0.81not close (p > 0.1)

The primary endpoint of 5-year OS did not reach statistical significance, with rates of 72% in the adjuvant chemotherapy group and 71% in the CCRT + BT group ( p = 0.81).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.